CTLA4 and neoplasm: While it has been previously published that anti-CTLA-4 or PD-1 monotherapy induces infiltration by TILs [105–108], this study suggests that CD8+ T cells infiltrating the tumor before therapy are particularly correlated with tumor response during therapy.